| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $708.0M | — | +18.4% |
| Cost of Revenue | $189.0M | — | +36.0% |
| Gross Profit | $519.0M | — | +13.1% |
| R&D Expense | $150.0M | — | +0.7% |
| SG&A Expense | $123.0M | — | +1.7% |
| Operating Income | $36.0M | — | +500.0% |
| Interest Expense | $4.0M | — | -20.0% |
| Pre-tax Income | $48.0M | — | +500.0% |
| Income Tax | $2.0M | — | — |
| Net Income | $46.0M | — | +475.0% |
| EPS (Basic) | $0.19 | — | +533.3% |
| EPS (Diluted) | $0.19 | — | +533.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $678.0M | -11.7% | -25.8% |
| Accounts Receivable | $153.0M | +2.7% | +33.0% |
| Current Assets | $1.66B | -21.8% | -23.0% |
| Total Assets | $5.23B | -8.1% | -9.0% |
| Current Liabilities | $724.0M | +6.6% | -17.3% |
| Total Liabilities | $818.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $200.0M | — | +92.3% |
| Capital Expenditures | $34.0M | — | -5.6% |
| Investing Cash Flow | $376.0M | — | +823.1% |
| Financing Cash Flow | -$666.0M | — | -204.1% |
| Free Cash Flow | $166.0M | — | +144.1% |
| -17.5% |
| Stockholders' Equity | $4.41B | -9.7% | -7.3% |